Photo of Philip Landrigan

Philip Landrigan

  • DEAN FOR GLOBAL HEALTH
  • PROFESSOR AND SYSTEM CHAIR Preventive Medicine
  • PROFESSOR Pediatrics
Print ProfilePrint Profile

Certifications

  • Occupational Medicine

  • American Board of Preventive Medicine

  • American Board of Pediatrics

Clinical Focus

  • Environmental Pediatrics
  • Exposure to toxic chemicals
  • Lead Poisoning
  • Pesticide Exposure

Training Areas

Education

  • MD, Harvard Medical School

  • AB, Boston College

  • Diploma of Industrial Health, University of London

  • M.Sc. in Occupational Medicine, London School of Hygiene and Tropical Medicine

  • Residency, Medicine/Pediatrics
    MetroHealth Medical Center

  • Residency, Pediatrics
    Children's Hospital Boston

  • Residency, Epideminology
    Center for Disease Control

Biography

    Philip J. Landrigan, M.D., M.Sc., the Ethel H. Wise Professor of Preventive Medicine, is a pediatrician and epidemiologist. He has been a member of the faculty of Mount Sinai School of Medicine since 1985 and Chair of the Department of Preventive Medicine since 1990. He was named Dean for Global Health in 2010. Dr. Landrigan is also the Director of the Children's Environmental Health Center.

    Dr. Landrigan graduated from Boston College in 1963 and from Harvard Medical School in 1967. He completed an internship in medicine/pediatrics at Cleveland Metropolitan General Hospital and a residency in pediatrics at Children's Hospital Boston. In 1977, he received a Diploma of Industrial Health from the University of London and a Masters of Science in Occupational Medicine degree from the London School of Hygiene and Tropical Medicine. He served for 15 years as an Epidemic Intelligence Service Officer and medical epidemiologist at the Centers for Disease Control and Prevention (CDC) and the National Institute for Occupational Safety and Health (NIOSH). While at CDC, Dr. Landrigan served for one year as a field epidemiologist in El Salvador and for much of another year in northern Nigeria. He participated in the Global Campaign for the Eradication of Smallpox. Dr. Landrigan directed the national program in occupational epidemiology for NIOSH. He was awarded the Meritorious Service Medal of the US Public Health Service.

    In 1987, Dr. Landrigan was elected a member of the Institute of Medicine of the National Academy of Sciences. He served as Editor-in-Chief of the American Journal of Industrial Medicine and Editor of Environmental Research. He has published more than 500 scientific papers and 5 books. He has chaired committees at the National Academy of Sciences on Environmental Neurotoxicology and on Pesticides in the Diets of Infants and Children. From 1995 to 1997, Dr. Landrigan served on the Presidential Advisory Committee on Gulf War Veteran's Illnesses. In 1997-1998, Dr. Landrigan served as Senior Advisor on Children's Health to the Administrator of the U.S. Environmental Protection Agency and was instrumental in helping to establish a new Office of Children's Health Protection at EPA. From 2000-2002, Dr. Landrigan served on the Armed Forces Epidemiological Board. Dr Landrigan served from 1996 to 2005 in the Medical Corps of the United States Naval Reserve. He retired in 2005 at the rank of Captain. He continues to serve as Surgeon General of the New York Naval Militia, New York's Naval National Guard.

    Dr. Landrigan is known for his many decades of work in protecting children against environmental threats to health. His research combines the tools of epidemiology with biological markers derived from clinical and laboratory medicine. Dr. Landrigan is deeply committed to translating research into strategies for health protection and disease prevention.

    Dr. Landrigan is featured in the NY Times OpEd Why Are We Subsidizing Childhood Obesity?.

Awards

  • 2011 -
    Frank R. Lautenberg Award in Public Health
    University of Medicine and Dentistry of New Jersey

  • 2009 -
    Stephen Smith Medal for Lifetime Achievement in Public Health
    New York Academy of Medicine

  • 2008 -
    Irving J. Selikoff Award
    Collegium Ramazzini

  • 2008 -
    Alumni Award for Professional Excellence
    Boston College

  • 2006 -
    Lifetime Achievement Award
    Children's Health Environmental Coalition

  • 2006 -
    Children's Environmental Health Champion Award
    Environmental Protection Agency

  • 2005 -
    Health Achievement in Occupational Medicine Award
    American College of Occupational and Environmental Medicine

  • 2005 -
    J. Lester Gabrilove Award
    Mount Sinai School of Medicine

  • 2003 -
    Jorma Rantanen Award
    Finnish Institute for Occupational Health

  • 2003 -
    David P. Rall Award for Advocacy in Public Health
    American Public Health Association

  • 2002 -
    Jacobi Medallion
    Mount Sinai School of Medicine

  • 2002 -
    Haven Emerson Award
    Public Health Association of New York City

  • 2002 -
    James Keogh Award
    National Institute for Occupational Safety and Health

  • 2000 -
    Award for Environmental Advocacy on Behalf of Children
    Environmental Advocates of New York

  • 2000 -
    William Steiger Memorial Award
    American Conference of Governmental Industrial Hygienists

  • 1999 -
    Katherine Boucot Sturgis Award
    American College of Preventive Medicine

  • 1998 -
    Vernon Houk Award
    International Society for Occupational and Environmental Health

  • 1995 -
    Occupational Health and Safety Award
    International Association of Fire Fighters

  • 1995 -
    Herbert L. Needleman Medal and Award for Scientific Contributions and Advocacy on Behalf of Children
    American Public Health Association

  • 1995 -
    William Sidell Presidential Award
    United Brotherhood of Carpenters

  • 1993 -
    Harriet Hardy Award
    New England College of Occupational and Environmental Medicine

  • 1987 -
    Elected Member
    Institute of Medicine

  • 1985 -
    Annual Honoree
    New York Committee for Occupational Safety and Health

Research

Dr. Landrigan’s landmark studies in the early 1970s of children exposed to lead near a lead ore smelter in El Paso, Texas were among the first to show that lead can cause brain damage to children at levels too low to cause clinically evident signs and symptoms – a phenomenon now termed “subclinical toxicity.” This work was critical in persuading the EPA to remove lead from gasoline and paint, actions that resulted in a 95% decline in lead poisoning in US children. This success has been emulated in nations worldwide.

The 1993 National Academy of Science report on Pesticides in the Diets of Infants and Children that Dr. Landrigan led provided the blueprint for the Food Quality Protection Act of 1996, the major law governing pesticide use in the US, and the only federal environmental law that contains explicit provisions for the protection of children’s health.



Dr. Landrigan has been a leader in developing and implementing the National Children's Study, the largest study of children's health and the environment ever launched in the United States. He has been centrally involved in the medical and epidemiologic studies that followed the destruction of the World Trade Center on September 11, 2001. He has consulted extensively to the World Health Organization.
In the News

Dr. Landrigan and his work  were recently profiled in The Daily News feature The Daily Check Up. View the PDF. Dr. Landrigan was also profiled in The Lancet in 2005. View profile.

Read the commentary by Philip J. Landrigan, MD, MSc, "What's Getting Into Our Children?" that appeared in the New York Times on August 4, 2009.

Publications

Landrigan PJ. What causes autism? Exploring the environmental contribution. Curr Opin Pediatr 2010; 22(2): 219-225.

Fleisch A, Sheffield P, Chinn C, Edelstein B, Landrigan PJ. Bisphenol A and Related Compounds in Dental Materials. Pediatrics 2010;.

Landrigan PJ, Trasande L, Thorpe LE. The National Children's Study: A 21-year prospective study of 100,000 American children. Pediatrics 2006; 118(5): 2173-2186.

Grandjean P, Landrigan PJ. Developmental Neurotoxicity of industrial chemicals: A silent pandemic. Lancet 2006; 368(9553): 2167-2178.

Herbert R, Moline J, Skloot G, Metzger K, Baron S, Luft B, Markowitz S, Udasin I, Harrison D, Stein D, Todd A, Enright P, Stellman JM, Landrigan PJ, Levin S. The World Trade Center Disaster and the Health of Workers: Five-Year Assessment of a Unique Medical Screening Program. Environ Health Perspect 2006; 114: 1853-1858.

Landrigan PJ, Lioy PJ, Berkowitz G, Chen LC, Chillrud CN, Georgopoulos PG, Geyh AS, Levin S, Perera F, Rappaport SM, Small C, Thurston G. Health and Environmental Consequences of the World Trade Center Disaster. Environ Health Perspect 2004; 112: 731-739.

Landrigan PJ, Schechter CB, Lipton JM, Fahs MC, Schwartz J. Environmental pollutants and disease in American children: Estimates of morbidity, mortality and costs for lead poisoning, asthma, cancer and developmental disabilities. Environ Health Perspect 2002; 110: 721-728.

Landrigan PJ, Carlson JE. Environmental policy and children's health. The Future of Children 1995; 5: 34-52.

Leigh JP, Markowitz SB, Fahs M, Shin C, Landrigan PJ. Occupational injury and illness in the United States. Estimates of costs, morbidity, and mortality. Arch Intern Med 1997; 157: 1557-1568.

Landrigan PJ, Gehlbach SH, Rosenblum BF, Shoults JM, Candelaria RM, Barthel WF, Liddle JA, Smrek AL, Staehling NW, Sanders JF. Epidemic lead absorption near an ore smelter: the role of particulate lead. New Engl J Med 1975; 292: 123-129.

Landrigan PJ, Whitworth RH, Baloh RW, Barthel WF, Staehling NW, Rosenblum BF. Neuropsychological dysfunction in children with chronic low-level lead absorption. Lancet 1975;: 708-712.

Landrigan PJ. Epidemic measles in a divided city. JAMA 1972 Aug; 221(6): 567-570.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Landrigan did not report having any of the following types of financial relationships with industry during 2013 and/or 2014: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

17 East 102 Street Room D3-145
New York, NY 10029


Address

17 East 102 Street
New York, NY 10029

Tel: 212-824-7018
Fax: 212-996-0407